Stocks picks for 2025: M&M, Sun Pharma, and Dalmia Bharat are the top three stock picks by Sumeet Bagadia of Choice Broking for the new year with significant potential for long-term-based returns.( ...

Sun Pharmaceutical Industries share price gained in the early trade on January 1 after the company is going to sell its entire holding in Japanese subsidiary. At 09:26am, Sun Pharmaceutical ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 inched up 0.39% to 1,854.15 Indian rupees Tuesday, on what proved to be an all-around great trading session for the stock market, with the BSE ...

Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.28% to 1,889.80 Indian rupees Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the ...

Cholecalciferol + risedronate sodium is under clinical development by Dongkook Pharmaceutical and currently in Phase I for Osteoporosis. According to GlobalData, Phase I drugs for Osteoporosis have a ...

Ionis Pharmaceuticals (Ionis), formerly Isis Pharmaceuticals ... For a complete picture of Obudanersen sodium’s drug-specific PTSR and LoA scores, buy the report here. GlobalData, the leading provider ...

Thus, it is expected that the stock may see a price target of Rs. 4270 in 8 to 10 months. Sun Pharma has been maintaining its bullish momentum as prices are seen holding well above its 200-DEMA on ...

Vibha D Sanghvi, one of the promoters of Sun Pharma, has acquired two premium apartments in the prestigious Naman Xana on Dr. Abdul Gaffar Khan Road in Worli with the total transaction amounting ...

Vidhi Shanghvi, daughter of Sun Pharma’s Dilip Shanghvi, plays a key role in the ₹4.35 lakh crore healthcare empire.(Photo via X (Twitter)) Vidhi Shanghvi, daughter of Dilip Shanghvi and Sun ...

Sun Pharma Advanced Research Company Ltd share price was down by -3.13% from the previous closing price of ₹189.45. Who are peers of Sun Pharma Advanced Research Company Ltd? The peers of Sun ...

Overview: Beijing Sun-Novo Pharmaceutical Research Co., Ltd. is a contract research company focused on drug research and development in China, with a market cap of CN¥4.37 billion. Operations: ...